Piascledin caps. 300mg # 30
Category
Anesthesia and muscle relaxants
,
Bruises, sprains
Scope of the drug
Musculoskeletal system
Release form
Capsules
Manufacturer country
France
Package quantity, pcs
thirty
Capsules (type I) with a white cap and an opaque white body, marked P 300"
the contents of the capsules are brown paste.
1 caps.
unsaponifiable compounds of avocado oil 100 mg
unsaponifiable compounds of soybean oil 200 mg
butylhydroxytoluene - 30 μg, colloidal silicon dioxide - 7 mg.
The composition of the capsule body: titanium dioxide - 2%, gelatin - up to 100%.
The composition of the capsule cap: titanium dioxide - 2%, gelatin - up to 100%.
The composition of the binder solution (for sealing the capsule): polysorbate 80 - 250 μg, gelatin - 5.75 mg.
Composition of TekPrint SW-9008 Black Ink (for capsule marking): shellac, ethanol, isopropanol, butanol, propylene glycol, concentrated ammonia solution, potassium hydroxide, black iron oxide.
15 pcs.
- blisters (2) - cardboard packs.
Name ENG
PIASCLEDINE 300
Clinical and pharmacological group
A drug that regulates metabolism in cartilage tissue
ATX code
Other drugs for topical use in diseases of the oral cavity, Other drugs for the treatment of diseases of the musculoskeletal system
Dosage
100mg + 200mg
Structure
Active ingredients: avocado oil unsaponifiable compounds 100 mg
soybean oil unsaponifiable compounds 200 mg
Excipients: butylhydroxytoluene
colloidal silicon dioxide
Capsule composition: titanium dioxide (E171)
gelatin
Indications
In rheumatology: as a component of complex therapy for osteoarthritis of the knee and hip joints of the 1st 3rd stage.
In dentistry: maintenance therapy for periodontitis.
Contraindications
Hypersensitivity to the constituent components of this drug
The drug is contraindicated during pregnancy and lactation, as well as in children under 18 years of age.
Storage conditions and periods
In a dark place at a temperature of 15-25 degrees.
Expiration date: 3 years
INN / Active ingredient
unsaponifiable compounds of avocado oil, unsaponifiable compounds of soybean oil
Specifications
Category
Anesthesia and muscle relaxants
,
Bruises, sprains
Scope of the drug
Musculoskeletal system
Release form
Capsules
Manufacturer country
France
Package quantity, pcs
thirty
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Expanscience
The amount of the dosage form in the primary package
15 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Anti-inflammatory agent
Dosage form
Capsules
Expiration date in days
1095
Drug action
Analgesic
,
Anti-inflammatory
,
Regenerating
Package weight, g
twenty
Mode of application
:
Inside, in the morning, during meals.
1 capsule of the drug Piaskledin 300 per day with 250 ml of water.
The course of treatment is 6 months.
Anatomical and therapeutic characteristics
:
M09AX Other drugs for the treatment of diseases of the musculoskeletal system
"